A recent report published by Infinium Global Research on active implantable medical devices market provides an in-depth analysis of segments and sub-segments in the global as well as regional active implantable medical devices market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional active implantable medical devices market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global active implantable medical devices market. According to the report, the global active implantable medical devices market is projected to grow at a CAGR of 4.6% over the forecast period of 2018-2024.
The report on global active implantable medical devices market covers segments such as product types. On the basis of product types, the sub-markets include implantable cardiac pacemakers, implantable defibrillators, implantable neuro stimulator systems, cochlear implants, haemodynamic support, implantable glucose monitors, insertable cardiac monitor (implantable monitoring devices), ventricular assist devices (VAD), implantable infusion pumps and accessories, and others.
The report provides profiles of the companies in the market such as Abbott, Medtronic, Boston Scientific Corporation, Nurotron Biotechnology Co. Ltd., LivaNova PLC, Biotronik Se & Co., Kg, Med-EL, Sonova Holding AG, and Cochlear Ltd.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter